Subscribe To
STE / Steris (STE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
 
  STE News
 
 
                          
                                By Zacks Investment Research                                
November 2, 2023
Steris (STE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how t more_horizontal
 
 
                          
                                By Zacks Investment Research                                
October 17, 2023
STERIS' (STE) Improved Volume, New Buyouts Drive Growth
On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments. more_horizontal
 
 
                          
                                By Zacks Investment Research                                
September 27, 2023
Here's Why Investors Should Retain STERIS (STE) Stock for Now
STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism. more_horizontal
 
 
                          
                                By Zacks Investment Research                                
August 22, 2023
Here's Why Investors Should Retain STERIS (STE) Stock for Now
Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance. more_horizontal
 
 
                          
                                By Zacks Investment Research                                
August 1, 2023
Steris (STE) Q1 Earnings and Revenues Beat Estimates
Steris (STE) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $ more_horizontal
 
 
                          
                                By Reuters                                
August 1, 2023
Medical device maker Steris lifts 2024 results view, records quarterly beat
Medical equipment provider Steris on Tuesday raised its profit forecast for fiscal 2024 after strength in its core healthcare business boosted first-q more_horizontal
 
 
                          
                                By Zacks Investment Research                                
June 22, 2023
STERIS (STE) Buys Surgical Instrumentation Platform From BDX
STERIS (STE) announces the buyout of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction. more_horizontal
 
 
                          
                                By Market Watch                                
June 20, 2023
Steris paying $540 mln for BD surgical instrument unit
Becton, Dickinson and Co. (BD) BDX, +0.96% said Tuesday it agreed to sell its surgical instrumentation platform to Steris for STE, +0.04% for $540 mil more_horizontal
 
             
